The expression of AIM2 has been shown to increase the number of sub-G1 phase cells and induce apoptosis in tumor cells, effectively inhibiting BC cell proliferation, and growth in vitro, as well as suppressing breast tumor formation in vivo. This evidence concerns the gene AIM2 and neoplasm.